134 related articles for article (PubMed ID: 27211090)
21. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
22. Receiver operating characteristic curve analysis, sensitivity comparison and individual difference.
Kawada T
Clin Radiol; 2012 Sep; 67(9):940. PubMed ID: 22608247
[No Abstract] [Full Text] [Related]
23. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
26. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
Karahan OI; Yikilmaz A; Artis T; Canoz O; Coskun A; Torun E
Eur J Radiol; 2006 Mar; 57(3):445-52. PubMed ID: 16337762
[TBL] [Abstract][Full Text] [Related]
28. Gd-DTPA-DeA: a novel, liver-specific MRI contrast agent.
Kawamura Y
Acad Radiol; 2002 May; 9 Suppl 1():S102-3. PubMed ID: 12019839
[No Abstract] [Full Text] [Related]
29. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.
Yoshida H; Itai Y; Ohtomo K; Kokubo T; Minami M; Yashiro N
Radiology; 1989 May; 171(2):339-42. PubMed ID: 2539606
[TBL] [Abstract][Full Text] [Related]
30. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
Chou CT; Chen YL; Su WW; Wu HK; Chen RC
J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
[TBL] [Abstract][Full Text] [Related]
32. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
[TBL] [Abstract][Full Text] [Related]
33. [Differentiation of focal liver lesions using contrast-enhanced MRT].
Heintz P; Ehrenheim C
Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
[TBL] [Abstract][Full Text] [Related]
34. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
35. Assessing patients with hepatocellular carcinoma meeting the Milan criteria: Is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT?
Cha DI; Lee MW; Kim YK; Kim SH; Park HJ; Rhim H; Lim HK
J Magn Reson Imaging; 2014 Apr; 39(4):842-52. PubMed ID: 24115384
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma and other hepatic malignancies: MR imaging.
Roth CG; Mitchell DG
Radiol Clin North Am; 2014 Jul; 52(4):683-707. PubMed ID: 24889167
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging.
Shimofusa R; Ueda T; Kishimoto T; Nakajima M; Yoshikawa M; Kondo F; Ito H
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):583-9. PubMed ID: 19809781
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
39. [MR imaging using Gd-DTPA in the evaluation of liver cancer].
Itai Y; Yoshioka H; Niitsu M; Anno I; Ohtomo K
Nihon Rinsho; 1991 Aug; 49(8):1826-31. PubMed ID: 1664888
[No Abstract] [Full Text] [Related]
40. Incidental focal hepatic mass.
Kim YC; Kim JK; Lee JH
Br J Radiol; 2013 Jan; 86(1021):20110659. PubMed ID: 23239688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]